P86.01 Phase 1 Study of the AXL Inhibitor DS-1205 in Combination With Osimertinib in Subjects With Metastatic or Unresectable EGFR-Mutant NSCLC
Year: 2021
Type: conference-abstract
Source: Journal of Thoracic Oncology
Authors: J.C. Yang, W. Su, C. Chiu, H. Shiah, K. Lee, T. Hsia, M. Uno, N. Crawford, H. Terakawa, W. Chen, G. Takayama, T. Limsakun, C. Hsu, E. Slosberg, G. Chang
Institutions: National Taiwan University Hospital, National Cheng Kung University Hospital, Taipei Veterans General Hospital, Taipei Medical University Hospital, Taipei Medical University-Shuang Ho Hospital, China Medical University Hospital, Daiichi-Sankyo (Japan), Daiichi Sankyo (United States), Taichung Veterans General Hospital
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W3149930894